PDCD1 and neoplasm: Given that the proportion of tumor-infiltrating TRM-like cells decrease in EGFR-MT lung tumors, which tends to show poor response to anti-PD-1 immunotherapy, we hypothesized that the relative abundance of TRM-like cells in the tumor by itself could predict the anti-PD-1 response.